AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
BABA   261.58 (+1.51%)
MU   49.98 (+0.54%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
F   5.84 (-4.11%)
GILD   74.71 (-1.19%)
DIS   116.81 (+0.13%)
BAC   22.77 (-1.43%)
NFLX   507.76 (+0.99%)
BA   173.28 (-3.78%)
Log in

NASDAQ:HRTXHeron Therapeutics News Headlines

$15.43
+0.42 (+2.80 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$14.95
Now: $15.43
$15.44
50-Day Range
$14.26
MA: $18.36
$21.01
52-Week Range
$9.60
Now: $15.43
$26.81
Volume1.48 million shs
Average Volume1.40 million shs
Market Capitalization$1.40 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.69

Headlines

Heron Therapeutics (NASDAQ HRTX) News Headlines

Source:
DateHeadline
Heron Therapeutics Inc (NASDAQ:HRTX) Receives Average Recommendation of "Buy" from BrokeragesHeron Therapeutics Inc (NASDAQ:HRTX) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - July 8 at 12:10 PM
FY2020 EPS Estimates for Heron Therapeutics Inc Increased by Cantor Fitzgerald (NASDAQ:HRTX)FY2020 EPS Estimates for Heron Therapeutics Inc Increased by Cantor Fitzgerald (NASDAQ:HRTX)
www.americanbankingnews.com - July 3 at 7:05 AM
Jefferies Financial Group Comments on Heron Therapeutics Incs FY2020 Earnings (NASDAQ:HRTX)Jefferies Financial Group Comments on Heron Therapeutics Inc's FY2020 Earnings (NASDAQ:HRTX)
www.americanbankingnews.com - July 2 at 9:18 AM
Q3 2020 EPS Estimates for Heron Therapeutics Inc (NASDAQ:HRTX) Decreased by SVB LeerinkQ3 2020 EPS Estimates for Heron Therapeutics Inc (NASDAQ:HRTX) Decreased by SVB Leerink
www.americanbankingnews.com - July 2 at 8:33 AM
Zacks: Analysts Expect Heron Therapeutics Inc (NASDAQ:HRTX) Will Announce Quarterly Sales of $15.45 MillionZacks: Analysts Expect Heron Therapeutics Inc (NASDAQ:HRTX) Will Announce Quarterly Sales of $15.45 Million
www.americanbankingnews.com - July 2 at 2:28 AM
U.S. FDA again declines to approve Heron Therapeutics non-opioid painkillerU.S. FDA again declines to approve Heron Therapeutics' non-opioid painkiller
www.nasdaq.com - July 1 at 6:39 PM
-$0.61 Earnings Per Share Expected for Heron Therapeutics Inc (NASDAQ:HRTX) This Quarter-$0.61 Earnings Per Share Expected for Heron Therapeutics Inc (NASDAQ:HRTX) This Quarter
www.americanbankingnews.com - June 30 at 5:50 PM
Herons Pain Management Drug Gets Complete Response LetterHeron's Pain Management Drug Gets Complete Response Letter
www.nasdaq.com - June 30 at 2:06 PM
Heron Therapeutics: The Play NowHeron Therapeutics: The Play Now
seekingalpha.com - June 30 at 2:06 PM
Heron's Pain Management Drug Gets Complete Response LetterHeron's Pain Management Drug Gets Complete Response Letter
finance.yahoo.com - June 30 at 2:06 PM
Heron Therapeutics (NASDAQ:HRTX) Shares Gap Down  Following Analyst DowngradeHeron Therapeutics (NASDAQ:HRTX) Shares Gap Down Following Analyst Downgrade
www.marketbeat.com - June 30 at 1:26 PM
Heron Therapeutics (NASDAQ:HRTX) Given New $19.00 Price Target at SVB LeerinkHeron Therapeutics (NASDAQ:HRTX) Given New $19.00 Price Target at SVB Leerink
www.marketbeat.com - June 30 at 11:28 AM
Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX)Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX)
www.americanbankingnews.com - June 30 at 8:04 AM
Stifel Nicolaus Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)Stifel Nicolaus Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)
www.americanbankingnews.com - June 30 at 6:33 AM
Mid-Day Market Update: Crude Oil Up 1.5%; Heron Therapeutics Shares PlummetMid-Day Market Update: Crude Oil Up 1.5%; Heron Therapeutics Shares Plummet
www.benzinga.com - June 29 at 1:43 PM
Stock Alert: Heron Therapeutics Slips 30% Following FDA LetterStock Alert: Heron Therapeutics Slips 30% Following FDA Letter
www.nasdaq.com - June 29 at 1:43 PM
FDA rejects Heron Therapeutics NDA for HTX-011 for postoperative painFDA rejects Heron Therapeutics' NDA for HTX-011 for postoperative pain
seekingalpha.com - June 29 at 1:43 PM
Heron Gets CRL For HTX-011 For Management Of Postoperative Pain; Stock DownHeron Gets CRL For HTX-011 For Management Of Postoperative Pain; Stock Down
www.nasdaq.com - June 29 at 1:42 PM
Why Heron Therapeutics Stock Is Tanking TodayWhy Heron Therapeutics Stock Is Tanking Today
www.fool.com - June 29 at 1:42 PM
Implied Volatility Surging for Heron Therapeutics (HRTX) Stock OptionsImplied Volatility Surging for Heron Therapeutics (HRTX) Stock Options
finance.yahoo.com - June 29 at 1:42 PM
Heron Therapeutics Target of Unusually Large Options Trading (NASDAQ:HRTX)Heron Therapeutics Target of Unusually Large Options Trading (NASDAQ:HRTX)
www.americanbankingnews.com - June 29 at 11:10 AM
Heron Therapeutics (NASDAQ:HRTX) Now Covered by Northland SecuritiesHeron Therapeutics (NASDAQ:HRTX) Now Covered by Northland Securities
www.americanbankingnews.com - June 23 at 1:40 PM
2 Top Healthcare Stocks to Watch in June2 Top Healthcare Stocks to Watch in June
finance.yahoo.com - June 16 at 10:20 AM
Postoperative Pain Therapeutics Market 2020-2025 | Industry Trends, Size, Share, Growth, Demand, COVID-19 Impact Analysis, And Future ScopePostoperative Pain Therapeutics Market 2020-2025 | Industry Trends, Size, Share, Growth, Demand, COVID-19 Impact Analysis, And Future Scope
www.marketwatch.com - June 15 at 8:01 AM
Herons Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaHeron's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 8 at 12:47 PM
Herons HTX-011 shows benefit in mid-stage knee replacement studyHeron's HTX-011 shows benefit in mid-stage knee replacement study
seekingalpha.com - June 4 at 12:30 PM
Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee ArthroplastyHeron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty
finance.yahoo.com - June 4 at 12:30 PM
Why Heron Therapeuticss Stock Is Trading Higher TodayWhy Heron Therapeutics's Stock Is Trading Higher Today
www.benzinga.com - May 27 at 2:39 PM
Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare StocksBillionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
finance.yahoo.com - May 20 at 10:49 AM
Heron launches study of HTX-034 for postop painHeron launches study of HTX-034 for postop pain
seekingalpha.com - May 18 at 2:46 PM
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative PainHeron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
finance.yahoo.com - May 18 at 9:46 AM
3 Best Healthcare Stocks to Buy in May3 Best Healthcare Stocks to Buy in May
finance.yahoo.com - May 9 at 8:12 AM
Earnings Update: Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - May 8 at 5:07 PM
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Industry – Growth, Trends, and Forecast (2020 – 2025)Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Industry – Growth, Trends, and Forecast (2020 – 2025)
www.marketwatch.com - May 7 at 2:29 PM
Heron Therapeutics EPS beats by $0.08, beats on revenueHeron Therapeutics EPS beats by $0.08, beats on revenue
seekingalpha.com - May 6 at 12:21 PM
Does Heron Therapeutics, Inc. (NASDAQ:HRTX) Have A Particularly Volatile Share Price?Does Heron Therapeutics, Inc. (NASDAQ:HRTX) Have A Particularly Volatile Share Price?
finance.yahoo.com - May 5 at 9:35 AM
2 Dirt-Cheap Growth Stocks to Buy Now2 Dirt-Cheap Growth Stocks to Buy Now
www.msn.com - April 9 at 10:04 PM
Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?
finance.yahoo.com - April 7 at 4:00 PM
Despite Lacking Profits Heron Therapeutics (NASDAQ:HRTX) Seems To Be On Top Of Its DebtDespite Lacking Profits Heron Therapeutics (NASDAQ:HRTX) Seems To Be On Top Of Its Debt
finance.yahoo.com - April 5 at 3:35 PM
Final Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and LeadFinal Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead
www.bloomberg.com - March 30 at 8:04 PM
Heron Therapeutics, Inc. Common Stock (HRTX) Option ChainHeron Therapeutics, Inc. Common Stock (HRTX) Option Chain
www.nasdaq.com - March 21 at 1:59 PM
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market 2020 Demand, Supply, Growth and Forecast to 2025Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market 2020 Demand, Supply, Growth and Forecast to 2025
www.marketwatch.com - March 18 at 8:06 AM
Heron Therapeutics Becomes Oversold (HRTX)Heron Therapeutics Becomes Oversold (HRTX)
www.nasdaq.com - March 6 at 12:25 PM
Heron Therapeutics (HRTX) Presents At SVB Leerink Global Healthcare Conference - SlideshowHeron Therapeutics (HRTX) Presents At SVB Leerink Global Healthcare Conference - Slideshow
seekingalpha.com - March 5 at 4:24 PM
Heron Therapeutics EPS misses by $0.09, beats on revenueHeron Therapeutics EPS misses by $0.09, beats on revenue
seekingalpha.com - March 2 at 7:55 AM
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate UpdatesHeron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
finance.yahoo.com - March 2 at 7:55 AM
Analysts: 3 Beaten-Down Stocks to Buy on WeaknessAnalysts: 3 Beaten-Down Stocks to Buy on Weakness
finance.yahoo.com - February 27 at 2:03 PM
Heron Therapeutics: Generic Competition And HTX-011 Approval May Put Pressure On Share PriceHeron Therapeutics: Generic Competition And HTX-011 Approval May Put Pressure On Share Price
seekingalpha.com - February 25 at 2:00 PM
Heron Therapeutics: Looking For Entry Following HTX-011 PDUFA ExtensionHeron Therapeutics: Looking For Entry Following HTX-011 PDUFA Extension
seekingalpha.com - February 21 at 6:42 PM
Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseHeron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - February 21 at 1:40 PM
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.